LEIPZIG, Germany, October 18 /PRNewswire/ -- Saxony's state minister for
Economics and Labor, Thomas Jurk, welcomes the arrival of In Vitro
Technologies GmbH (IVT) into the Bio City Leipzig. "I wish IVT a successful
start in Europe. The decision of the US concern to locate to Leipzig shows
that we have successfully developed Saxony into an attractive location for
biotechnology," said Jurk. IVT produces cell-based test systems used in
pharmaceutical and chemical-biological research.
IVT is a wholly owned subsidiary of In Vitro Technologies, Inc. (IVT
Inc), a leading company in the field of in vitro systems for drug discovery
and development applications. IVT Inc.'s President and Chief Executive
Officer, Dr. Paul M. Silber, commented: "Europe is of strategic importance to
IVT's growth plans and a physical presence in Europe is a direct response to
our customers needs for quick access to our products. Biosaxony's support was
crucial in selecting Leipzig for our operations." Mr. Lalit Gaur, Sr. Manager
Business Development of IVT Inc., further added: "The Bio City Leipzig offers
us everything we need for a successful start in Europe: a cluster of
internationally renowned researchers for potential collaborations,
availability of trained and skilled technical staff, and optimal conditions.
We need fast logistic access to our European markets for our time-critical
products. With DHL, we can ship and deliver our products from Leipzig within
24 hours."
Dr. Hinnerk Boriss, European Manager for IVT, praised the support he
received from the biosaxony team: "They arranged contacts to research
scientists, accompanied the foundation of the German Company, and opened the
doors to the most important contacts concerned with founding the company
within the shortest period of time. The biosaxony Start-Up package
facilitated a smooth transition from entry to establishment of business in
Europe."
IVT Inc. was founded in 1990 in Baltimore, Maryland, USA and currently
employs over 70 people. IVT is a recognized leader in the development,
production, sale and trade of in vitro testing products and services for
studying chemical-biological interactions in vitro. One of its key products,
Hepatocytes (liver cells), for example, is used in the early determination of
clinical parameters (metabolism, drug-drug interactions) and toxicology
profile for new drug candidates by the pharmaceutical and biotechnology
industriesy. This is an essential step in testing new drug candidates. IVT
produces cryogenically-preserved, in vitro cell products from human and
animal hepatocytesspecies. The use of Tthese systems provides another
alternative for animal testing and helps reduce the need for testing in
animals.
http://www.invitrotech.de
Contact:
Mr. Lalit Gaur
In Vitro Technologies, Inc.
1450 S. Rolling Road
Baltimore, MD 21227
Phone: +1-410-455-1242
Email: gaurl@invitrotech.com
Dr. Hinnerk Boriss
In Vitro Technologies GmbH
Deutscher Platz 5 c
04103 Leipzig
Phone: +49-341-492-71-555
Email: borissh@invitrotech.de
SOURCE biosaxony
 back to top
CONTACT:
Mr. Lalit Gaur, In Vitro Technologies, Inc.
1450 S. Rolling Road, Baltimore, MD 21227, Phone:
+1-410-455-1242, Email: gaurl@invitrotech.com. Dr. Hinnerk
Boriss, In Vitro Technologies GmbH, Deutscher Platz 5 c, 04103
Leipzig, Phone: +49-341-492-71-555, Email: borissh@invitrotech.de
|
